Mallinckrodt Public Limited Company Shares Outstanding 2012-2018 | MNK

Mallinckrodt Public Limited Company shares outstanding from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Mallinckrodt Public Limited Company Annual Shares Outstanding
(Millions of Shares)
2017 98
2016 0
2016 112
2015 117
2014 65
2013 58
2012 0
2012 58
2011 0
2011 58
2010 0
Mallinckrodt Public Limited Company Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 85
Q2 2018 83
Q1 2018 86
Q4 2017 98
Q3 2017 97
Q2 2017 99
Q1 2017 104
Q4 2016 0
Q3 2016 109
Q2 2016 109
Q1 2016 112
Q4 2015 116
Q3 2015 0
Q2 2015 118
Q1 2015 117
Q4 2014 116
Q3 2014 85
Q2 2014 59
Q1 2014 59
Q4 2013 58
Q3 2013 58
Q2 2013 58
Q1 2013 58
Q4 2012 58
Q3 2012 58
Q2 2012 58
Q3 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.568B $3.222B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.630B 9.04
Teva Pharmaceutical Industries (TEVA) Israel $22.371B 6.85
Mylan (MYL) United Kingdom $17.841B 7.35
Bausch Health Cos (BHC) Canada $8.219B 5.95
Dr Reddy's Laboratories (RDY) India $5.845B 23.34
Supernus Pharmaceuticals (SUPN) United States $2.211B 20.95
Amphastar Pharmaceuticals (AMPH) United States $0.945B 102.55
Akorn (AKRX) United States $0.851B 0.00
Homology Medicines (FIXX) United States $0.720B 0.00
Assembly Biosciences (ASMB) United States $0.622B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.439B 0.00
Voyager Therapeutics (VYGR) United States $0.377B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Teligent (TLGT) United States $0.117B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.089B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Acasti Pharma (ACST) Canada $0.053B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00